Journal
EBioMedicine
Publication Date
2018
Volume
37
Inclusive Pages
366-373
Document Type
Open Access Publication
DOI
10.1016/j.ebiom.2018.10.038
Rights and Permissions
Gupta S, Lau K, Harding CO, et al (2018) Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. EBioMedicine, 27:366-373. https://doi.org/10.1016/j.ebiom.2018.10.038 © 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Gupta, Soumi; Lau, Kelly; Harding, Cary O.; Shepherd, Gillian; Boyer, Ryan; Atkinson, John P.; Knight, Vijaya; Olbertz, Joy; Larimore, Kevin; Gu, Zhonghu; Li, Mingjin; Rosen, Orli; Zoog, Stephen J.; Weng, Haoling H.; and Shweighardt, Becky, "Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials." EBioMedicine. 37, 366-373. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7381
Supplementary material
